Sold as Glycine 1.5% In Plastic Container, Aminoacetic Acid 1.5% In Plastic Container. Every FDA application for this active ingredient.
As of Nov 15, 2026, FDA lists 5 applications for Glycine (sold as Glycine 1.5% In Plastic Container, Aminoacetic Acid 1.5% In Plastic Container), first approved May 25, 1976, with 0 new uses approved and 0 published complete response letters.
| May 25, 1976 | Glycine 1.5% In Plastic ContainerNDA 17633 · New formulation or manufacturer | Hospira | 43 | Discontinued |
| Feb 6, 1978 | Glycine 1.5% In Plastic ContainerNDA 16784 · New formulation or manufacturer | B Braun | 30 | Marketed |
| Feb 22, 1980 | Glycine 1.5% In Plastic ContainerNDA 18315 · New formulation or manufacturer | Otsuka Icu Medcl | 44 | Marketed |
| May 30, 1980 | Aminoacetic Acid 1.5% In Plastic ContainerNDA 17865 · New formulation or manufacturer | Baxter Hlthcare | 37 | Marketed |
| — | Glycine 1.5% In Plastic ContainerNDA 18522 | Baxter Hlthcare | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
Baxter Hlthcare